10-Q: ReposiTrak Reports Strong Q1 Growth, Boosts Dividend

Sentiment:

Quarterly Report


ReposiTrak, Inc. announced a 10% revenue increase and higher net income for the quarter ended September 30, 2025, alongside a dividend hike and strong liquidity.

Delay expectedThe deadline for compliance with FSMA 204 was extended by 30 months to July 20, 2028.
Better than expectedRevenue increased by 10% year-over-year, indicating strong top-line growth.Net income applicable to common shareholders grew by 13%, demonstrating improved profitability.Basic and diluted earnings per share both increased.The company increased its quarterly cash dividend by 10% and continued its share repurchase program, signaling confidence in future performance and commitment to shareholder returns.Termination of the revolving credit facility highlights a strong financial position with zero bank debt.

Summary

  • Revenue for the three months ended September 30, 2025, increased by 10% to $5,971,467, up from $5,441,142 in the prior year period.
  • Net income applicable to common shareholders rose by 13% to $1,760,712, compared to $1,557,273 for the same period last year.
  • Basic earnings per share increased to $0.10 from $0.09, and diluted earnings per share increased to $0.09 from $0.08.
  • Cash and cash equivalents stood at $28,794,806 as of September 30, 2025, a 1% increase from June 30, 2025.
  • Working capital improved by $745,095, reaching $28,899,777 as of September 30, 2025.
  • The current ratio strengthened to 6.45 at September 30, 2025, from 6.09 at June 30, 2025.
  • Net cash provided by operating activities decreased by 18% to $1,538,447, primarily due to increases in accounts receivable and prepaid expenses, and a decrease in deferred revenue.
  • The company repurchased $149,985 of common stock during the quarter, with $7,642,188 remaining under the Share Repurchase Program.
  • Preferred stock redemptions totaled $749,995 for the quarter, with $2,846,254 of Preferred Stock remaining to be redeemed.
  • The Board of Directors declared a quarterly cash dividend of $0.02 per share, representing the third 10% increase since September 2022.
  • The company terminated its $10.0 million revolving credit facility with U.S. Bank N.A. in March 2024, citing a strong financial position and zero bank debt.

Sentiment

Score: 8

Explanation: ReposiTrak demonstrates robust financial health with significant revenue growth, increased profitability, and a strong balance sheet. The company's strategic focus on food safety and traceability, particularly with the evolving FSMA 204 regulations and accelerated retailer mandates, positions it well for continued expansion in a critical industry segment. Consistent dividend increases and an active share repurchase program further enhance shareholder value, making it an attractive investment. The decrease in operating cash flow is noted but explained by working capital dynamics.

Positives

  • Revenue increased by 10% year-over-year, driven by growth in recurring subscription revenue across all business lines (compliance, supply chain, and traceability).
  • Net income applicable to common shareholders grew by 13%, leading to improved basic and diluted earnings per share.
  • Strong liquidity position with cash and cash equivalents of $28,794,806 and a significant increase in working capital to $28,899,777.
  • The current ratio improved to 6.45, indicating robust short-term financial health.
  • Preferred dividends decreased by 45% due to ongoing redemption and retirement of Preferred Stock, reducing future dividend obligations.
  • The company terminated its revolving credit facility, demonstrating financial independence and strength with zero bank debt.
  • Consistent shareholder returns through an active share repurchase program and a 10% increase in the quarterly cash dividend.
  • Strategic positioning in the growing food traceability market, driven by federal regulations (FSMA 204) and accelerated mandates from major retailers.

Negatives

  • Net cash provided by operating activities decreased by 18% ($330,453) year-over-year, primarily due to an increase in accounts receivable and prepaid expenses, and a decrease in deferred revenue.
  • Realized loss on short-term investments of $20,246 was recorded during the quarter.
  • Interest income growth may not be sustainable in future periods due to Federal Reserve interest rate cuts that began in September 2024.

Risks

  • Future capital requirements depend on macroeconomic conditions, revenue growth rate, sales and marketing activities, and R&D spending.
  • The company's ability to maintain interest income on cash balances may be challenged by falling interest rates without taking on additional credit risk.
  • Goodwill and other long-lived assets are subject to impairment reviews, and changes in circumstances could lead to impairment losses.
  • Estimates and assumptions used in financial reporting, particularly for revenue recognition, goodwill, and income taxes, could differ from actual results.
  • The company's hub-and-spoke business model relies on retailers and wholesalers mandating its services to their suppliers, which could be a risk if adoption slows.

Future Outlook

Management believes existing cash and short-term investments, combined with funds from operations, will be sufficient to cover operating and investment requirements for at least the next twelve months. The company anticipates continued increases in cash flow from operations and working capital, which will be partially offset by quarterly cash dividends and ongoing preferred stock redemptions. Sales and marketing expenses, excluding variable costs, are expected to stabilize over the next twelve months as the FSMA 204 traceability deadline approaches and industry adoption continues. The company intends to redeem all remaining Series B and B-1 Preferred Stock on or before December 2026. However, future interest income may be negatively impacted by recent Federal Reserve interest rate cuts.

Management Comments

  • Randall K. Fields, CEO, and John R. Merrill, CFO, certified that the report does not contain any untrue statement of a material fact or omit to state a material fact, and that financial statements fairly present the financial condition, results of operations, and cash flows.
  • Management believes all adjustments necessary for a fair presentation of the interim financial information have been made and are of a normal recurring nature.
  • Management believes that existing cash and short-term investments, together with funds generated from operations, are sufficient to fund operating and investment requirements for at least the next twelve months.
  • Management currently believes that the Company will continue to increase its cash flow from operations and working capital position in subsequent periods.

Industry Context

The food supply chain industry is undergoing a significant transformation towards comprehensive traceability, driven by both regulatory mandates and competitive pressures. The FDA's Food Safety Modernization Act Section 204(d) (FSMA 204) requires traceability for high-risk foods, necessitating the capture and sharing of Key Data Elements (KDEs) at Critical Tracking Events (CTEs). Although the FSMA 204 compliance deadline was extended to July 20, 2028, major retailers are imposing earlier and more stringent traceability requirements, often for all foods, not just those on the FDA's Food Traceability List. ReposiTrak's Traceability Network (RTN) is strategically positioned to capitalize on this trend, offering a low-cost, easy-to-deploy solution to meet these evolving industry demands, leveraging its extensive network of food suppliers, wholesalers, and retailers.

Comparison to Industry Standards

  • Major retailers are setting traceability requirements that are more robust than the FDA's FSMA 204, including additional data elements, traceability for all foods, and accelerated timelines (e.g., by June 30, 2025). ReposiTrak's solutions are designed to meet these advanced industry demands.
  • ReposiTrak claims its Traceability Network (RTN) is the 'largest connected network of food suppliers, wholesalers and retailers in the world,' positioning it as a leader in providing end-to-end traceability.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Certification of ControlsChief Executive Officer and Chief Financial Officer evaluated and confirmed the effectiveness of disclosure controls and procedures and internal control over financial reporting as of September 30, 2025.September 30, 2025Ensures material information is recorded, processed, summarized, and reported timely, providing reasonable assurance regarding financial reporting reliability.

Legal Proceedings

  • The company is involved in various legal proceedings incidental to its business, but historically, these have not had a material adverse effect on its financial condition or operations.
  • There are currently no pending or threatened material legal proceedings that, in management's opinion, could have a material adverse effect on the business or financial condition.

Related Party Transactions

  • Paid Riverview Financial Corp (controlled by CEO Randall K. Fields) $256,404 for executive management services during the three months ended September 30, 2025.
  • Redeemed $749,995 in Series B Preferred Stock from Randall K. Fields, his affiliates, and director Robert W. Allen during the three months ended September 30, 2025.

Stakeholder Impact

  • Shareholders benefit from increased dividends, ongoing share repurchases, and the company's strong financial performance and strategic market positioning.
  • Customers gain from enhanced compliance, traceability, and supply chain management solutions, which are increasingly critical due to regulatory and retailer mandates.
  • Employees are impacted by stock compensation expense and higher employee benefit costs.
  • Creditors face reduced risk due to the company's strong liquidity and the termination of its bank credit facility, indicating zero bank debt.

Next Steps

  • Continue focusing sales efforts on marketing software services on a recurring subscription basis.
  • Further develop software for the ReposiTrak platform to accurately meet FSMA 204 requirements and accelerate systematic customer onboarding.
  • Redeem the remaining $2.85 million of Preferred Stock on or before December 2026.
  • Pay the declared quarterly cash dividend on or about November 14, 2025.
  • Monitor the impact of Federal Reserve interest rate cuts on future interest income.
  • Adopt ASU 2023-09 (Improvements to Income Tax Disclosures) for annual reporting in fiscal year 2026.
  • Adopt ASU 2024-03 (Disaggregation of Income Statement Expenses) for annual reporting in fiscal year 2028 and interim reporting in the first quarter of fiscal year 2029.

Key Dates

DateDescription
August 29, 2023Board approved the redemption and retirement of Series B and B-1 Preferred Stock over a three-year period.
December 21, 2023Company changed its corporate name from Park City Group, Inc. to ReposiTrak, Inc.
March 15, 2024Company chose not to renew its Revolving Credit Agreement with U.S. Bank N.A.
September 2024Federal Reserve began cutting interest rates.
June 30, 2025Deadline for several major retailers requiring suppliers to meet unique traceability requirements, years before FDA enforcement.
September 19, 2025Board of Directors declared a quarterly cash dividend of $0.02 per share.
September 30, 2025End of the quarterly period covered by this report and record date for the declared dividend.
November 13, 2025Date of filing this quarterly report on Form 10-Q.
November 14, 2025Approximate payment date for the declared quarterly cash dividend.
December 2026Target date for the company to redeem all remaining Series B and B-1 Preferred Stock.
Fiscal year 2026Required adoption period for ASU 2023-09 (Improvements to Income Tax Disclosures).
July 20, 2028Extended compliance deadline for FSMA 204.
Fiscal year 2028Required adoption period for ASU 2024-03 (Disaggregation of Income Statement Expenses).
First quarter of fiscal year 2029Beginning of interim period reporting for ASU 2024-03.

Recommendation

strong buy

ReposiTrak demonstrates robust financial health with significant revenue growth, increased profitability, and a strong balance sheet. The company's strategic focus on food safety and traceability, particularly with the evolving FSMA 204 regulations and accelerated retailer mandates, positions it well for continued expansion in a critical industry segment. Consistent dividend increases and an active share repurchase program further enhance shareholder value, making it an attractive investment. The slight dip in operating cash flow is attributable to working capital changes and does not detract from the overall positive performance.

Keywords

ReposiTrak, SaaS, supply chain management, food safety, compliance, traceability, FSMA 204, quarterly report, financial results, dividend, share repurchase, SEC filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.